525 related articles for article (PubMed ID: 30970562)
1. The Key Role of Phosphate on Vascular Calcification.
Cozzolino M; Ciceri P; Galassi A; Mangano M; Carugo S; Capelli I; Cianciolo G
Toxins (Basel); 2019 Apr; 11(4):. PubMed ID: 30970562
[TBL] [Abstract][Full Text] [Related]
2. CKD, arterial calcification, atherosclerosis and bone health: Inter-relationships and controversies.
Reiss AB; Miyawaki N; Moon J; Kasselman LJ; Voloshyna I; D'Avino R; De Leon J
Atherosclerosis; 2018 Nov; 278():49-59. PubMed ID: 30253289
[TBL] [Abstract][Full Text] [Related]
3. Advances in pharmacotherapy for hyperphosphatemia in renal disease.
Spasovski G
Expert Opin Pharmacother; 2015; 16(17):2589-99. PubMed ID: 26374200
[TBL] [Abstract][Full Text] [Related]
4. OGT knockdown counteracts high phosphate-induced vascular calcification in chronic kidney disease through autophagy activation by downregulating YAP.
Xu TH; Sheng Z; Li Y; Qiu X; Tian B; Yao L
Life Sci; 2020 Nov; 261():118121. PubMed ID: 32693242
[TBL] [Abstract][Full Text] [Related]
5. Oxidative stress contributes to vascular calcification in patients with chronic kidney disease.
Huang M; Zheng L; Xu H; Tang D; Lin L; Zhang J; Li C; Wang W; Yuan Q; Tao L; Ye Z
J Mol Cell Cardiol; 2020 Jan; 138():256-268. PubMed ID: 31866376
[TBL] [Abstract][Full Text] [Related]
6. SGK3 promotes vascular calcification via Pit-1 in chronic kidney disease.
Dong QQ; Tu YC; Gao P; Liao QQ; Zhou P; Zhang H; Shu HP; Sun LL; Feng L; Yao LJ
Theranostics; 2024; 14(2):861-878. PubMed ID: 38169564
[No Abstract] [Full Text] [Related]
7. Derangements in phosphate metabolism in chronic kidney diseases/endstage renal disease: therapeutic considerations.
Molony DA; Stephens BW
Adv Chronic Kidney Dis; 2011 Mar; 18(2):120-31. PubMed ID: 21406297
[TBL] [Abstract][Full Text] [Related]
8. The Role of Vitamin K in Vascular Calcification.
Cozzolino M; Fusaro M; Ciceri P; Gasperoni L; Cianciolo G
Adv Chronic Kidney Dis; 2019 Nov; 26(6):437-444. PubMed ID: 31831122
[TBL] [Abstract][Full Text] [Related]
9. Phosphate binders prevent phosphate-induced cellular senescence of vascular smooth muscle cells and vascular calcification in a modified, adenine-based uremic rat model.
Yamada S; Tatsumoto N; Tokumoto M; Noguchi H; Ooboshi H; Kitazono T; Tsuruya K
Calcif Tissue Int; 2015 Apr; 96(4):347-58. PubMed ID: 25511229
[TBL] [Abstract][Full Text] [Related]
10. CKAP4 contributes to the progression of vascular calcification (VC) in chronic kidney disease (CKD) by modulating YAP phosphorylation and MMP2 expression.
Shi Y; Jin X; Yang M; Jia J; Yao H; Yuan W; Wang K; Rong S
Cell Signal; 2022 May; 93():110270. PubMed ID: 35108641
[TBL] [Abstract][Full Text] [Related]
11. Connections between vascular calcification and progression of chronic kidney disease: therapeutic alternatives.
Hruska KA; Mathew S; Davies MR; Lund RJ
Kidney Int Suppl; 2005 Dec; (99):S142-51. PubMed ID: 16336568
[TBL] [Abstract][Full Text] [Related]
12. Spironolactone dose‑dependently alleviates the calcification of aortic rings cultured in hyperphosphatemic medium with or without hyperglycemia by suppressing phenotypic transition of VSMCs through downregulation of Pit‑1.
Wang P; Quan Z; Luo D; Chen W; Peng D
Mol Med Rep; 2019 May; 19(5):3622-3632. PubMed ID: 30896801
[TBL] [Abstract][Full Text] [Related]
13. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
14. Effect of cross-linked chitosan iron (III) on vascular calcification in uremic rats.
de Castro BBA; do Carmo WB; de Albuquerque Suassuna PG; Carminatti M; Brito JB; Dominguez WV; de Oliveira IB; Jorgetti V; Custodio MR; Sanders-Pinheiro H
Exp Biol Med (Maywood); 2018 May; 243(9):796-802. PubMed ID: 29763365
[TBL] [Abstract][Full Text] [Related]
15. HDAC1-mediated deacetylation of LSD1 regulates vascular calcification by promoting autophagy in chronic renal failure.
Zhou J; Zhou H; Liu C; Huang L; Lu D; Gao C
J Cell Mol Med; 2020 Aug; 24(15):8636-8649. PubMed ID: 32596952
[TBL] [Abstract][Full Text] [Related]
16. Hyperphosphatemia-induced degradation of transcription factor EB exacerbates vascular calcification.
Ishiwata R; Morimoto Y
Biochim Biophys Acta Mol Basis Dis; 2022 Mar; 1868(3):166323. PubMed ID: 34921974
[TBL] [Abstract][Full Text] [Related]
17. Phosphate overload directly induces systemic inflammation and malnutrition as well as vascular calcification in uremia.
Yamada S; Tokumoto M; Tatsumoto N; Taniguchi M; Noguchi H; Nakano T; Masutani K; Ooboshi H; Tsuruya K; Kitazono T
Am J Physiol Renal Physiol; 2014 Jun; 306(12):F1418-28. PubMed ID: 24808541
[TBL] [Abstract][Full Text] [Related]
18. Phosphate binders for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis: a comparison of safety profiles.
Locatelli F; Del Vecchio L; Violo L; Pontoriero G
Expert Opin Drug Saf; 2014 May; 13(5):551-61. PubMed ID: 24702470
[TBL] [Abstract][Full Text] [Related]
19. Role of crosstalk between endothelial cells and smooth muscle cells in vascular calcification in chronic kidney disease.
Zhang YX; Tang RN; Wang LT; Liu BC
Cell Prolif; 2021 Mar; 54(3):e12980. PubMed ID: 33502070
[TBL] [Abstract][Full Text] [Related]
20. Calcium Overload Accelerates Phosphate-Induced Vascular Calcification Via Pit-1, but not the Calcium-Sensing Receptor.
Masumoto A; Sonou T; Ohya M; Yashiro M; Nakashima Y; Okuda K; Iwashita Y; Mima T; Negi S; Shigematsu T
J Atheroscler Thromb; 2017 Jul; 24(7):716-724. PubMed ID: 27840385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
